- |||||||||| Woulgan (yeast beta-glucan) / Biotec
Journal: Analysis of the proteins secreted by Trichoderma harzianum P49P11 under carbon-limited conditions. (Pubmed Central) - Jun 22, 2021
As far as we know, this is the first work about the continuous synthesis of enzymes under carbon-limited conditions suggesting that different easily assimilated carbon sources can be used to generate different enzymatic cocktails. Each enzyme or uncharacterized protein suggested by shotgun proteomics has the potential to become a promising product for biotechnological applications.
- |||||||||| Woulgan (yeast beta-glucan) / Biotec
Review, Journal: Immunomodulating Effects of Fungal Beta-Glucans: From Traditional Use to Medicine. (Pubmed Central) - May 8, 2021
In addition to these developments related to food uses of beta-glucan-containing supplements, beta-glucans could also hold a novel position in Western medicine as the concept of trained immunity is relatively new and has not been investigated to a large extent. These innovative concepts, together with the emerging success of modern immunological and biotechnological methods, suggest that fungal glucans may play a promising role in both perspectives, and that there are possibilities for traditional medicine to provide an immunological application in both medicine and nutrition.
- |||||||||| Woulgan (yeast beta-glucan) / Biotec
Trial completion, Trial completion date, Trial primary completion date: Evaluation of Woulgan in Diabetic Foot Ulcer (clinicaltrials.gov) - May 30, 2019
P4, N=62, Completed,
These innovative concepts, together with the emerging success of modern immunological and biotechnological methods, suggest that fungal glucans may play a promising role in both perspectives, and that there are possibilities for traditional medicine to provide an immunological application in both medicine and nutrition. Recruiting --> Completed | Trial completion date: Dec 2018 --> Apr 2019 | Trial primary completion date: Oct 2018 --> Dec 2018
- |||||||||| Woulgan (yeast beta-glucan) / Biotec
Trial primary completion date: Evaluation of Woulgan in Diabetic Foot Ulcer (clinicaltrials.gov) - Feb 1, 2018
P4, N=80, Recruiting,
Recruiting --> Completed | Trial completion date: Dec 2018 --> Apr 2019 | Trial primary completion date: Oct 2018 --> Dec 2018 Trial primary completion date: Oct 2017 --> Oct 2018
|
